… lifestyles but also because of our newfound dietary needs. GLP-1s, for example, have created a new customer: people trying to mitigate potential muscle atrophy, a side effect of rapid weight loss, by…
…at Eli Lilly and Novo Nordisk would drop the price of their GLP-1 weight-loss drugs and sell them on a Trump-branded website, both companies were also granted vouchers for new weight-loss drugs. Makar…
…ore likely to lose weight and improve blood sugar levels on GLP-1 medications. But people who eat mainly in response to stress, sadness, or emotional struggles didn’t see the same long-term benefits.
…ration obesity drug that works like a “Trojan horse,” using GLP-1/GIP signals to slip a powerful metabolic enhancer directly into target cells. In mice, it outperformed existing treatments—curbing app…
…inally, they unpack why alcohol stocks are struggling while GLP-1 drugs are booming, and what that says about the future of American consumer behavior. Looking for the full version? Become a Prof G+ s…
…n vs. Zohran Mamdani: The pied-à-terre tax fight, explained GLP-1 drugs are coming for big alcohol Today at 10 a.m. ET, Scott and Ed are going live with Professor Aswath Damodaran. On tap: Big Tech ea…
…aken in. Three hormones play central roles in this process. GLP-1, which you may recognize from the headlines about weight-loss drugs, is one your body makes on its own every time you eat. It is relea…
…f a dark chocolate Magnum, a talking British Shorthair cat, GLP-1 stories, belly overhangs and proclamations that smoking is the new cool (even I can’t justify that one). It’s a far cry from the calm,…
…ck. But first we needed a taller ladder. That ladder is the GLP-1 drug revolution, which shows no signs of slowing down. In December 2025, Eli Lilly, the most valuable pharmaceutical company in the wo…
…Wall Street 📱 Samsung: AI Chip Profits Explode 💊 Eli Lilly: GLP-1 Volume Engine Roars 💳 Visa: Fastest Growth Since 2022 💳 Mastercard: Cross-Border Cracks Show ⏳ AbbVie: Skyrizi and Rinvoq Deliver 🥤 Co…
…rowth trajectory is unlike anything in its history. Lilly’s GLP-1 franchise, Mounjaro for type 2 diabetes and Zepbound for obesity, generated a combined $36.5 billion in FY2025 revenue, representing 5…
… once you start it becomes so hard not to do more. Dysport, GLP-1s, filler... I did some in addition but not others. You’re never going to look like Emma Stone unless you get actual plastic surgery.” …
…tion. Tirzepatide (microdose): Sunday only. It’s a next-gen GLP-1 receptor agonist. David and I discussed this at the Abundance Summit. Beyond weight loss, GLP-1s are showing remarkable benefits for t…
Novo Nordisk recently slashed prices for its popular diabetes medications Ozempic and Wegovy in India by up to 48%, following the expiration of its patent on semaglutide. This has led to a flood of generic alternatives from Indian pharmaceutical companies, with prices plummeting by as much as 90%. India has a history of capitalizing on expired patents to produce affordable generics, making it a key player in the global pharmaceutical market. However, creating a generic version of semaglutide is far more complex than typical drugs. Semaglutide mimics the natural GLP-1 hormone, which is difficult to replicate due to its intricate structure and the specific modifications that enhance its stability in the bloodstream. The manufacturing process involves solid-phase peptide synthesis, which is labor-intensive and generates significant waste. Even with advancements, achieving the necessary purity and accuracy in production remains a challenge. Indian companies like Dr. Reddy's and Zydus have invested heavily in developing the capability to produce semaglutide, launching their generics as soon as the patent expired. However, regulatory hurdles have emerged, particularly in markets like Canada, where additional data is required for approval. This scrutiny reflects the complexities associated with peptide drugs, which differ significantly from standard small-molecule generics. While the Indian market for semaglutide is substantial, it pales in comparison to Novo Nordisk's revenues from the US and Europe, where the majority of sales occur. The US patent for semaglutide won't expire until 2032, giving Novo Nordisk several more years of exclusivity in its most lucrative markets. As Indian companies navigate these challenges, the landscape of diabetes treatment continues to evolve, with potential implications for global pricing and accessibility.
… to fearmonger. Not all peptides are dangerous. Insulin and GLP-1 medications like semaglutide (Ozempic) are peptides with clinical trial data and FDA-approvals for specific use cases. The concern is …
By Morgan McSweeney, PhD (@dr.noc) Most people think of GLP-1 drugs as weight loss medications. That’s not wrong. But it’s increasingly incomplete - and the part that’s missing might matter more t…
…es about her new novel (ish) and why she’s hesitant to take GLP-1s. Novelists on writing true. On Eating, a new book from Alicia Kennedy, is out now, and there’s an excerpt in her newsletter, which I …
Does my pony need a GLP-1? We are living in the age of Ozempic. Dinner parties, group chats, circuit gossip, Real Housewives confessionals, your husband’s best …
…n. Throw in the fact that sales from Lilly’s newly-approved GLP-1 pill Foundayo weren’t included in the latest earnings report and that Medicare will start offering weight-loss drugs through a bridge …
… weight is finally over for Novo Nordisk. Novo launched its GLP-1 pill, the oral version of Wegovy, in January, and the results are in: Doctors scribbled 1.3 million prescriptions in the first quarter…
…guidance as medical costs fell sharply. - Novo Nordisk: The GLP-1 drug maker raised its guidance after its first oral weight loss pill got off to a promising start with 2 million prescriptions already…
…by $2 billion, expecting big things from its newly launched GLP-1 pill. The details. The drugmaker’s Q1 revenue of $19.8 billion beat Wall Street’s expected $17.62 billion and was up 56%, compared wit…
… My theory is that this actually has nothing to do with the GLP-1s. I think the food is just too pretty and no one wants to be that person who ruins it? This is an issue. Beyond the wasted food, it le…
…While certain peptides have been made widely available like GLP-1s, their popularity has normalized a market of un-related injections that are not subject to typical quality control. What could go wro…
…ites in The Remarkable Life of the Skin. Isn’t that lovely? GLP-1s like Ozempic and Zepbound are “being studied for just about everything,” Dr. Wechsler told me, including compulsive behaviors like BF…
… puffiness and lymphatic issues – and the widespread use of GLP-1s. “People who are on Ozempic or are dieting heavily are really thin, and don’t have enough fat to transfer,” Doft says. “They want the…
…lutide… 🎶 I spoke to Sara Radin at Vogue about “The Rise of GLP-1 Wedding Weight Loss.” Wedding culture has historically centered on the bride’s appearance. Yet increasingly, grooms and partners of al…
…ssie McMillan Cottom video about the “everyday eugenics” of GLP-1s to your Instagram story and see who responds. Another option: connect and commiserate. “I don’t try to dissuade them from their persp…
…re here, courtesy of Juice Brides and grooms are turning to GLP-1s to lose weight pre-wedding Lushful Aesthetics offers HoleTox (butthole Botox) “to make receiving anal sex (bottoming) easier” Quadran…
…sm. Beyond detoxing, specific nutrients can naturally mimic GLP-1 without the side effects of drugs. Berberine has been shown in rat studies to naturally increase GLP-1 secretion, while Ceylon cinnamo…